Black Opal Ventures

AuthMind is a firm specializing in identity security. It employs access neural network technologies to identify and prevent hidden identity risks continuously.

Parasail is an AI deployment networking company that provides AI products to builders and innovators for secure compute.

Conceivable Life Sciences is developing an AI-powered automated IVF lab to increase accessibility to in vitro fertilization.

Hyro develops a conversational artificial intelligence platform that enhances user interactions across various digital channels. By leveraging natural language understanding, the platform allows organizations to create plug-and-play AI assistants capable of engaging customers through voice and chat. Hyro's innovative approach enables seamless ingestion of existing data to automatically build knowledge graphs, facilitating frictionless deployment and maintenance without the need for integration, playbooks, or extensive training data. The platform also features an advanced analytics dashboard, allowing organizations to customize conversations and improve customer engagement effectively.

Hyro develops a conversational artificial intelligence platform that enhances user interactions across various digital channels. By leveraging natural language understanding, the platform allows organizations to create plug-and-play AI assistants capable of engaging customers through voice and chat. Hyro's innovative approach enables seamless ingestion of existing data to automatically build knowledge graphs, facilitating frictionless deployment and maintenance without the need for integration, playbooks, or extensive training data. The platform also features an advanced analytics dashboard, allowing organizations to customize conversations and improve customer engagement effectively.

Optellum Ltd is a UK-based company founded in 2015 that specializes in artificial intelligence clinical decision support software specifically for lung cancer diagnosis and treatment. The company has developed an imaging biomarker aimed at enhancing the early detection of lung cancer, the most prevalent and deadly form of cancer globally. Optellum's innovative platform leverages machine learning to analyze vast patient datasets, enabling personalized diagnosis and therapy management for patients at high risk of developing lung cancer. The software not only identifies at-risk patients but also facilitates optimal therapy by automating the analysis of radiology reports, thereby improving clinical decision-making. The founding team consists of experts in medical imaging software and AI, with experience in successfully bringing innovations to market. Optellum is supported by a distinguished Advisory Board of clinicians and deep learning specialists, and is actively expanding its product development team to further its mission in cancer care.

Empatica Inc. is a Cambridge, Massachusetts-based company that specializes in the development of wearable medical sensor devices aimed at health monitoring, forecasting, treatment, and research. Founded in 2013, Empatica creates AI-enabled wearables, including the E3 wristband, which monitors physiological signals in real time, along with accompanying software applications and web dashboards for stress and sleep analysis. The company's technology employs a combination of biosensors to capture and analyze unique aspects of human physiology, offering valuable insights to patients, clinicians, and researchers. Notable clients include Microsoft Research, Sony, University of Trento, and Intel, highlighting the company's impact in the field of health technology.

Synteny.Ai Syntney decodes the signals of immune repertoires to help biotech research and pharma companies with disease discoveries.